Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, octubre 31
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Exelixis Inc
EXEL
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$69.39
3.19
4.82%
Últ. Act.: Oct 30, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
PRO
¿Por qué se mueve?:
Exelixis shares are trading higher after the company reported better-than-e...
Ganancias:
Los beneficios de Q3 2026 se publicaron el jue oct 29th, después del cierre del mercado
Conferencia telefónica:
La conferencia telefónica más reciente comenzó a las 5:00 p. m., hace 1 día
Haz clic para ver el webcast
Exelixis Financials
Exelixis (EXEL) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Exelixis Affirms FY2026 Sales Guidance of $2.500B-$2.550B vs $2.549B Est
Exelixis (NASDAQ:EXEL) affirms FY2026 sales outlook from $2.500 billion-$2.550 billion to $2.500 billion-$2.550 billion vs $2.549 billion estimate.
Benzinga Newsdesk
PRO
Exelixis Q3 Adj. EPS $0.94 Beats $0.80 Estimate, Sales $658.696M Beat $646.510M Estimate
Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.80 by 17.5 percent. This is a 20.51 percent increase over earnings of $0.78 per share from the same
Benzinga Newsdesk
PRO
Exelixis Lowers FY2026 Sales Guidance from $2.525B-$2.625B to $2.500B-$2.550B vs $2.595B Est
Exelixis (NASDAQ:EXEL) lowers FY2026 sales outlook from $2.525 billion-$2.625 billion to $2.500 billion-$2.550 billion vs $2.595 billion estimate.
Benzinga Newsdesk
PRO
Exelixis Q2 Adj. EPS $0.91 Beats $0.79 Estimate, Sales $628.700M Miss $635.951M Estimate
Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.79 by 15.19 percent. This is a 21.33 percent increase over earnings of $0.75 per share from the same
Benzinga Newsdesk
PRO
Exelixis Affirms FY2026 Sales Guidance of $2.525B-$2.625B vs $2.583B Est
Exelixis (NASDAQ:EXEL) affirms FY2026 sales outlook from $2.525 billion-$2.625 billion to $2.525 billion-$2.625 billion vs $2.583 billion estimate.
Benzinga Newsdesk
PRO
Exelixis Q1 Adj. EPS $0.87 Beats $0.70 Estimate, Sales $610.812M Beat $605.196M Estimate
Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.70 by 24.29 percent. This is a 40.32 percent increase over earnings of $0.62 per share from the same
Benzinga Newsdesk
